Bone regenerative therapy by octacalcium phosphate (OCP) collagen composites

Bone regenerative therapy by octacalcium phosphate (OCP) collagen composites - Bone regenerative therapy by octacalcium phosphate (OCP) collagen composites

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004655

Enrollment

Registered

2010-12-11

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth extraction socket, Cyst hole

Interventions

Implantation of OCP collagen composites into bone defects affected with cystectomy or tooth extraction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatient/Outpatient: no specification Disease/ Severity: A cyst below 5 cm in longest diameters of radiographic examination Affected period: no specification Treatment period: no specification Patients who can provide written informed consent

Exclusion criteria

Exclusion criteria: Patient suffering severe hepatopathy, renal disorders, and heart disease who would affect safety evaluation of this trial Patient who has an allergy drug Patient who is pregnant, possibly pregnant, nursing or considering pregnancy Patient who participated other clinical trial program within 3 months prior to the study entry Others, patient who is unfit for the study as determined by the principal investigator or sub-investigators

Design outcomes

Primary

Measure	Time frame
Safety assessment by clinical examination and adverse event	—

Secondary

Measure	Time frame
Radiographic examination	—

Countries

Japan

Contacts

Public ContactShinji KAMAKURA

Tohoku University Bone Regenerative Engineering Laboratory, Graduate School of Biomedical Engineering

kamakura@bme.tohoku.ac.jp022-717-8235

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026